𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson’s disease

✍ Scribed by Mitul A. Mehta; B. J. Sahakian; Peter J. McKenna; Trevor W. Robbins

Book ID
105885075
Publisher
Springer
Year
1999
Tongue
English
Weight
142 KB
Volume
146
Category
Article
ISSN
0033-3158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparison of the mini mental state ex
A comparison of the mini mental state exam to the montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease
✍ Cindy Zadikoff; Susan H. Fox; David F. Tang-Wai; Teri Thomsen; Rob M.A. de Bie; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Abstract Dementia is an important and increasingly recognized problem in Parkinson's disease (PD). The mini‐mental state examination (MMSE) often fails to detect early cognitive decline. The Montreal cognitive assessment (MoCA) is a brief tool developed to detect mild cognitive impairment that a

The effects of rasagiline on cognitive d
The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: A randomized, double-blind, placebo-controlled, multicenter study
✍ Hasmet A. Hanagasi; Hakan Gurvit; Pınar Unsalan; Hilal Horozoglu; Nese Tuncer; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef